Aedifica NV/SA (LON:0DKX)
66.10
+0.10 (0.15%)
At close: Nov 7, 2025
Aedifica NV/SA Revenue
Aedifica NV/SA had revenue of 93.45M EUR in the quarter ending September 30, 2025, with 5.81% growth. This brings the company's revenue in the last twelve months to 366.52M, up 7.62% year-over-year. In the year 2024, Aedifica NV/SA had annual revenue of 346.54M with 7.92% growth.
Revenue (ttm)
366.52M EUR
Revenue Growth
+7.62%
P/S Ratio
8.68
Revenue / Employee
2.80M EUR
Employees
131
Market Cap
2.78B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 346.54M | 25.43M | 7.92% |
| Dec 31, 2023 | 321.11M | 41.88M | 15.00% |
| Dec 31, 2022 | 279.23M | 36.50M | 15.04% |
| Dec 31, 2021 | 242.73M | 64.14M | 35.91% |
| Dec 31, 2020 | 178.59M | 9.77M | 5.79% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |